ロード中...
Tyrosine Kinase Inhibitors in Lung Cancer
‘Driver mutations’ are essential for carcinogenesis as well as tumor progression as they confer a selective growth advantage to cancer cells. Identification of driver mutations in growth related protein kinases, especially tyrosine kinases have led to clinical development of an array of tyrosine kin...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3334853/ https://ncbi.nlm.nih.gov/pubmed/22520981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2012.02.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|